Table 3.
Compound | NONMEM model structures testeda,b | First-order (FO) or first-order conditional (FOCE) estimation | Covariates analyzedc |
---|---|---|---|
Citalopram, IV | ADVAN3, TRANS4 | FOCE with interaction | Continuous: age, body-mass index, fat mass, fat-free mass, weight |
Discrete: sex | |||
DMAG, IV | ADVAN3, TRANS4 | FOCE with interaction | Continuous: age, albumin, alanine aminotransferase, aspartate transaminase, bilirubin, blood urea nitrogen, body surface area, creatinine, weight |
ADVAN11, TRANS4 | |||
(And possible inter-occasion variability on clearance, central volume, and first inter-compartment clearance) | |||
Discrete: sex | |||
Escitalopram, oral [21] | ADVAN2, TRANS2 | FOCE with interaction | Continuous: age, body-mass index, weight |
ADVAN4, TRANS4 | Discrete: clinical site, CYP2C19 genotype, race, sex | ||
Olanzapine, oral [14] | ADVAN2, TRANS2 | FOCE with interaction | Continuous: age |
ADVAN4, TRANS4 | Discrete: race, sex, smoking status | ||
Perphenazine, oral [15] | ADVAN2, TRANS2 | FOCE with interaction | Continuous: age, number of cigarettes per day, weight |
ADVAN4, TRANS4 | |||
Discrete: race, sex, smoking status, concomitant medication use | |||
Risperidone, oral [16] | ADVAN2, TRANS2 | FO | Continuous: age, weight |
ADVAN4, TRANS4 | Discrete: race, sex, smoking status, concomitant medication use | ||
(And 1, 2, or 3 clearance subpopulations) | |||
Ziprasidone, oral [17] | ADVAN2, TRANS2 | FOCE with interaction | Continuous: age, height, number of cigarettes per day, weight |
Discrete: race, sex, smoking status, concomitant medication use |
aADVAN2 is a one-compartment linear model with first order absorption, ADVAN3 is a two compartment linear model; ADVAN4 is a two compartment linear model with first order absorption; and ADVAN11 is a three compartment linear model
bTRANS2 with ADVAN2 specifies model options for clearance (CL) and volume of distribution (V); TRANS4 with ADVAN3 or ADVAN4 specifies model options for CL, central volume (V1), inter-compartment clearance (Q), and peripheral volume (V2); and TRANS4 with ADVAN11 specifies model options for CL, V1, first inter-compartment clearance (Q1), V2, second inter-compartment clearance (Q2), and third compartment volume (V3)